Now, you can focus on what really matters: pushing the boundaries of science
Learn more about comprehensive peptides for anti-aging strategies and how GHK-CU fits into broader protocols

Retatrutide shows potential for greater efficacy through triple-agonism but awaits Phase 3 results Best For Recommendations# Currently Available Treatment# Recommendation : Tirzepatide Reason : FDA-approved and commercially available as Mounjaro/Zepbound with established dosing protocols and post-market safety data Maximum Weight Loss Potential# Recommendation : Retatrutide Reason : Phase 2 data showed 24.2% weight loss at 48 weeks, exceeding tirzepatide's results, though Phase 3 confirmation is pending Non-Alcoholic Fatty Liver Disease# Recommendation : Retatrutide Reason : Glucagon receptor agonism directly promotes hepatic fat oxidation, showing up to 82% liver fat reduction in trials Type 2 Diabetes Management# Recommendation : Tirzepatide Reason : Proven HbA1c reduction with FDA approval specifically for glycemic control in type 2 diabetes Further Reading# Which Is Better For

User 19 ran 500mcg twice daily for 13 weeks across a chronic multi-injury case involving a 10-year back injury and a 4-year shoulder injury, adding GHK-Cu, ipamorelin, and CJC-1295 to the protocol, and reported 90 percent pain relief after one cycle
Electron microscopy can be used to show sickle-shaped T whipplei bacteria with their trilaminar cell wall